La traduction de cette page est expérimentale et en cours de développement. N'hésitez pas à vos !
COLO B Aperçu des actions
Coloplast A/S développe et vend des produits et des services de soins intimes au Danemark, aux États-Unis, au Royaume-Uni, en France et dans le monde entier.
Score flocon de neige | |
---|---|
Évaluation | 3/6 |
Croissance future | 2/6 |
Performances passées | 2/6 |
Santé financière | 1/6 |
Dividendes | 3/6 |
Récompenses
Analyse des risques
Coloplast A/S Concurrents
Historique des prix et performances
Historique des cours de bourse | |
---|---|
Prix actuel de l'action | DKK 900.80 |
Plus haut sur 52 semaines | DKK 977.60 |
Plus bas sur 52 semaines | DKK 689.20 |
Bêta | 0.32 |
1Variation sur 1 mois | 2.55% |
Variation sur 3 mois | 4.82% |
Variation sur 1 an | 12.94% |
3Variation sur 3 ans | -17.92% |
Variation sur 5 ans | 11.79% |
Évolution depuis l'introduction en bourse | 6,949.74% |
Nouvelles et mises à jour récentes
Subdued Growth No Barrier To Coloplast A/S' (CPH:COLO B) Price
Jul 17These 4 Measures Indicate That Coloplast (CPH:COLO B) Is Using Debt Reasonably Well
Jun 29Coloplast's (CPH:COLO B) Solid Earnings May Rest On Weak Foundations
May 21Coloplast (CPH:COLO B) Is Due To Pay A Dividend Of DKK5.00
May 10Recent updates
Subdued Growth No Barrier To Coloplast A/S' (CPH:COLO B) Price
Jul 17These 4 Measures Indicate That Coloplast (CPH:COLO B) Is Using Debt Reasonably Well
Jun 29Coloplast's (CPH:COLO B) Solid Earnings May Rest On Weak Foundations
May 21Coloplast (CPH:COLO B) Is Due To Pay A Dividend Of DKK5.00
May 10Analyst Estimates: Here's What Brokers Think Of Coloplast A/S (CPH:COLO B) After Its Interim Report
May 09A Look At The Fair Value Of Coloplast A/S (CPH:COLO B)
Apr 26There's Reason For Concern Over Coloplast A/S' (CPH:COLO B) Price
Apr 08Is Coloplast (CPH:COLO B) A Risky Investment?
Mar 21Estimating The Intrinsic Value Of Coloplast A/S (CPH:COLO B)
Jan 09Coloplast A/S' (CPH:COLO B) Price Is Out Of Tune With Earnings
Dec 22These 4 Measures Indicate That Coloplast (CPH:COLO B) Is Using Debt Reasonably Well
Dec 04Coloplast (CPH:COLO B) Strong Profits May Be Masking Some Underlying Issues
Nov 16A Look At The Intrinsic Value Of Coloplast A/S (CPH:COLO B)
Sep 30Is Coloplast (CPH:COLO B) A Risky Investment?
Jun 28Coloplast A/S' (CPH:COLO B) Intrinsic Value Is Potentially 18% Below Its Share Price
Jun 10Coloplast (CPH:COLO B) Seems To Use Debt Quite Sensibly
Mar 22Coloplast A/S' (CPH:COLO B) Intrinsic Value Is Potentially 25% Below Its Share Price
Mar 01These 4 Measures Indicate That Coloplast (CPH:COLO B) Is Using Debt Reasonably Well
Dec 14Coloplast's (CPH:COLO B) Upcoming Dividend Will Be Larger Than Last Year's
Nov 26Here's Why We Think Coloplast A/S' (CPH:COLO B) CEO Compensation Looks Fair for the time being
Nov 25Coloplast's (CPH:COLO B) Shareholders Will Receive A Bigger Dividend Than Last Year
Nov 11With EPS Growth And More, Coloplast (CPH:COLO B) Makes An Interesting Case
Oct 25Estimating The Fair Value Of Coloplast A/S (CPH:COLO B)
Aug 26These 4 Measures Indicate That Coloplast (CPH:COLO B) Is Using Debt Reasonably Well
Jul 27Here's Why We Think Coloplast (CPH:COLO B) Is Well Worth Watching
Jul 12Is There An Opportunity With Coloplast A/S' (CPH:COLO B) 45% Undervaluation?
May 23Coloplast (CPH:COLO B) Is Due To Pay A Dividend Of kr.5.00
May 08Coloplast (CPH:COLO B) Seems To Use Debt Rather Sparingly
Apr 13Here's Why I Think Coloplast (CPH:COLO B) Is An Interesting Stock
Mar 29Coloplast A/S (CPH:COLO B) Shares Could Be 41% Below Their Intrinsic Value Estimate
Feb 12Coloplast (CPH:COLO B) Could Easily Take On More Debt
Jan 12Is Now The Time To Put Coloplast (CPH:COLO B) On Your Watchlist?
Dec 28Why We Think Coloplast A/S' (CPH:COLO B) CEO Compensation Is Not Excessive At All
Nov 25A Look At The Fair Value Of Coloplast A/S (CPH:COLO B)
Oct 31Here's Why Coloplast (CPH:COLO B) Can Manage Its Debt Responsibly
Oct 02Do Coloplast's (CPH:COLO B) Earnings Warrant Your Attention?
Sep 16Does This Valuation Of Coloplast A/S (CPH:COLO B) Imply Investors Are Overpaying?
Aug 02Rendement pour les actionnaires
COLO B | DK Medical Equipment | DK Marché | |
---|---|---|---|
7D | -2.1% | 0.7% | -0.3% |
1Y | 12.9% | 11.3% | 25.4% |
Rendement vs Industrie: COLO B a dépassé le secteur Danish Medical Equipment qui a rapporté 11.3 % au cours de l'année écoulée.
Rendement vs marché: COLO B a sous-performé le marché Danish qui a rapporté 27.3 % au cours de l'année écoulée.
Volatilité des prix
COLO B volatility | |
---|---|
COLO B Average Weekly Movement | 3.1% |
Medical Equipment Industry Average Movement | 5.7% |
Market Average Movement | 4.3% |
10% most volatile stocks in DK Market | 9.1% |
10% least volatile stocks in DK Market | 2.8% |
Cours de l'action stable: COLO B n'a pas connu de volatilité de prix significative au cours des 3 derniers mois.
Volatilité au fil du temps: La volatilité hebdomadaire de COLO B ( 3% ) est restée stable au cours de l'année écoulée.
À propos de l'entreprise
Fondée | Salariés | PDG | Site web |
---|---|---|---|
1954 | 16,019 | Kristian Villumsen | www.coloplast.com |
Coloplast A/S développe et vend des produits et des services de soins intimes au Danemark, aux États-Unis, au Royaume-Uni, en France et dans le monde entier. La société opère à travers les segments Chronic Care, Continence Care, Voice and Respiratory Care, Interventional Urology, et Advanced Wound Care. Elle fournit des produits de soins pour stomies, notamment SenSura Mio, qui s'adapte aux formes corporelles individuelles et offre une discrétion optimale pour divers types de stomies, et SenSura Ostomy care solutions, ainsi que des accessoires pour stomies sous la marque Brava.
Coloplast A/S Résumé des fondamentaux
COLO B statistiques fondamentales | |
---|---|
Capitalisation boursière | DKK 199.61b |
Bénéfices(TTM) | DKK 4.97b |
Recettes(TTM) | DKK 26.30b |
40.8x
Ratio P/E7.7x
Ratio P/SLe site COLO B est-il surévalué ?
Voir Juste valeur et analyse de l'évaluationBénéfices et recettes
COLO B compte de résultat (TTM) | |
---|---|
Recettes | DKK 26.30b |
Coût des recettes | DKK 8.54b |
Marge brute | DKK 17.76b |
Autres dépenses | DKK 12.79b |
Les revenus | DKK 4.97b |
Derniers bénéfices déclarés
Jun 30, 2024
Prochaine date de publication des résultats
Nov 05, 2024
Résultat par action (EPS) | 22.09 |
Marge brute | 67.52% |
Marge bénéficiaire nette | 18.88% |
Ratio dettes/capitaux propres | 142.3% |
Quelles ont été les performances à long terme de COLO B?
Voir les performances historiques et les comparaisons